Prospective Study
Copyright ©The Author(s) 2018.
World J Gastroenterol. Jun 7, 2018; 24(21): 2300-2310
Published online Jun 7, 2018. doi: 10.3748/wjg.v24.i21.2300
Figure 2
Figure 2 Acute kidney injury staging, progression and the response to terlipressin in ACLF-AKI and DC-AKI patients. A: AKI stages at diagnosis (P = 0.396); B: Peak stages of AKI (P = 0.039); C: Progression of AKI (P = 0.013); D: Patient’s response to terlipressin (P = 0.018). All analyses compared by fisher's exact test or chi-square test, P < 0.05 were considered as have statistically significant.